Hyaluronan synthase 1: A mysterious enzyme with unexpected functions

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Siiskonen, Hanna ^a   Oikari, Sanna ^b   Pasonen Seppänen, Sanna ^b   Rilla, Kirsi ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cancer; CD44; Cytokines; Hyaluronan; Hyaluronan synthase; Inflammation

Indexed keywords

ABC TRANSPORTER; HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 2; HYALURONAN SYNTHASE 3; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; SYNTHETASE; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CANCER GROWTH; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME SYNTHESIS; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG DISEASE; METABOLIC SYNDROME X; NEOPLASM; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; REVIEW; STREPTOCOCCUS PYOGENES; UPREGULATION;

EID: 84926651240     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00043     Document Type: Review

References (121)

1. Tammi RH, Passi AG, Rilla K, Karousou E, Vigetti D, Makkonen K, et al. Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J (2011) 278(9):1419-28. doi:10.1111/j.1742-4658.2011.08070.x
2. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A Jr, et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest (2000) 106(3):349-60. doi:10.1172/JCI10272
3. Kobayashi N, Miyoshi S, Mikami T, Koyama H, Kitazawa M, Takeoka M, et al. Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. Cancer Res (2010) 70(18):7073-83. doi:10.1158/0008-5472.CAN-09-4687
4. Bai KJ, Spicer AP, Mascarenhas MM, Yu L, Ochoa CD, Garg HG, et al. The role of hyaluronan synthase 3 in ventilator-induced lung injury. Am J Respir Crit Care Med (2005) 172(1):92-8. doi:10.1164/rccm.200405-652OC
5. Mack JA, Feldman RJ, Itano N, Kimata K, Lauer M, Hascall VC, et al. Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3. J Invest Dermatol (2012) 132(1):198-207. doi:10.1038/jid.2011.248
6. Högnäs G, Tuomi S, Veltel S, Mattila E, Murumagi A, Edgren H, et al. Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo. Oncogene (2012) 31(31):3597-606. doi:10.1038/onc.2011.527
7. Adamia S, Kriangkum J, Belch AR, Pilarski LM. Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression. Adv Cancer Res (2014) 123:67-94. doi:10.1016/B978-0-12-800092-2.00003-4
8. Auvinen P, Rilla K, Tumelius R, Tammi M, Sironen R, Soini Y, et al. Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival. Breast Cancer Res Treat (2014) 143(2):277-86. doi:10.1007/s10549-013-2804-7
9. Qu C, Rilla K, Tammi R, Tammi M, Kröger H, Lammi MJ. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3. Int J Biochem Cell Biol (2014) 48C:45-54. doi:10.1016/j.biocel.2013.12.016
10. Malaisse J, Bourguignon V, De Vuyst E, Lambert de Rouvroit C, Nikkels AF, Flamion B, et al. Hyaluronan metabolism in human keratinocytes and atopic dermatitis skin is driven by a balance of hyaluronan synthases 1 and 3. J Invest Dermatol (2014) 134(8):2174-82. doi:10.1038/jid.2014.147
11. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, et al. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem (1999) 274(35):25085-92. doi:10.1074/jbc.274.35.25085
12. Rilla K, Oikari S, Jokela TA, Hyttinen JM, Kärnä R, Tammi RH, et al. Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3. J Biol Chem (2013) 288(8):5973-83. doi:10.1074/jbc.M112.443879
13. Siiskonen H, Kärnä R, Hyttinen JM, Tammi RH, Tammi MI, Rilla K. Hyaluronan synthase 1 (HAS1) produces a cytokine-and glucose-inducible, CD44-dependent cell surface coat. Exp Cell Res (2014) 320(1):153-63. doi:10.1016/j.yexcr.2013.09.021
14. Törrönen K, Nikunen K, Kärnä R, Tammi M, Tammi R, Rilla K. Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes. Histochem Cell Biol (2014) 141(1):17-31. doi:10.1007/s00418-013-1143-4
15. Weigel PH, DeAngelis PL. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem (2007) 282(51):36777-81. doi:10.1074/jbc.R700036200
16. DeAngelis PL, Papaconstantinou J, Weigel PH. Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J Biol Chem (1993) 268(26):19181-4.
17. Shyjan AM, Heldin P, Butcher EC, Yoshino T, Briskin MJ. Functional cloning of the cDNA for a human hyaluronan synthase. J Biol Chem (1996) 271(38):23395-9. doi:10.1074/jbc.271.38.23395
18. Itano N, Kimata K. Molecular cloning of human hyaluronan synthase. Biochem Biophys Res Commun (1996) 222(3):816-20. doi:10.1006/bbrc.1996.0827
19. Spicer AP, Seldin MF, Olsen AS, Brown N, Wells DE, Doggett NA, et al. Chromosomal localization of the human and mouse hyaluronan synthase genes. Genomics (1997) 41(3):493-7. doi:10.1006/geno.1997.4696
20. Monslow J, Williams JD, Norton N, Guy CA, Price IK, Coleman SL, et al. The human hyaluronan synthase genes: genomic structures, proximal promoters and polymorphic microsatellite markers. Int J Biochem Cell Biol (2003) 35(8):1272-83. doi:10.1016/S1357-2725(03)00048-7
21. Adamia S, Crainie M, Kriangkum J, Mant MJ, Belch AR, Pilarski LM. Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia. Semin Oncol (2003) 30(2):165-8. doi:10.1053/sonc.2003.50042
22. Adamia S, Reiman T, Crainie M, Mant MJ, Belch AR, Pilarski LM. Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma. Blood (2005) 105(12):4836-44. doi:10.1182/blood-2004-10-3825
23. Golshani R, Hautmann SH, Estrella V, Cohen BL, Kyle CC, Manoharan M, et al. HAS1 expression in bladder cancer and its relation to urinary HA test. Int J Cancer (2007) 120(8):1712-20. doi:10.1002/ijc.22222
24. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem (1997) 272(22):13997-4000. doi:10.1074/jbc.272.22.13997
25. Markovitz A, Cifonelli JA, Dorfman A. The biosynthesis of hyaluronic acid by group A Streptococcus. VI. Biosynthesis from uridine nucleotides in cell-free extracts. J Biol Chem (1959) 234:2343-50.
26. Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem J (1984) 220(2):597-600.
27. Prehm P. Synthesis of hyaluronate in differentiated teratocarcinoma cells. Characterization of the synthase. Biochem J (1983) 211(1):181-9.
28. Asplund T, Brinck J, Suzuki M, Briskin MJ, Heldin P. Characterization of hyaluronan synthase from a human glioma cell line. Biochim Biophys Acta (1998) 1380(3):377-88. doi:10.1016/S0304-4165(98)00010-5
29. Prehm P. Biosynthesis of hyaluronan: direction of chain elongation. Biochem J (2006) 398(3):469-73. doi:10.1042/BJ20060431
30. Bodevin-Authelet S, Kusche-Gullberg M, Pummill PE, DeAngelis PL, Lindahl U. Biosynthesis of hyaluronan: direction of chain elongation. J Biol Chem (2005) 280(10):8813-8. doi:10.1074/jbc.M412803200
31. DeAngelis PL. Molecular directionality of polysaccharide polymerization by the Pasteurella multocida hyaluronan synthase. J Biol Chem (1999) 274(37):26557-62. doi:10.1074/jbc.274.37.26557
32. Prehm P. Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth. Biochem J (1983) 211(1):191-8.
33. Schulz T, Schumacher U, Prehm P. Hyaluronan export by the ABC transporter MRP5 and its modulation by intracellular cGMP. J Biol Chem (2007) 282(29):20999-1004. doi:10.1074/jbc.M700915200
34. Hagenfeld D, Borkenhagen B, Schulz T, Schillers H, Schumacher U, Prehm P. Hyaluronan export through plasma membranes depends on concurrent K+ efflux by K(ir) channels. PLoS One (2012) 7(6):e39096. doi:10.1371/journal.pone.0039096
35. Thomas NK, Brown TJ. ABC transporters do not contribute to extracellular translocation of hyaluronan in human breast cancer in vitro. Exp Cell Res (2010) 316(7):1241-53. doi:10.1016/j.yexcr.2010.01.004
36. Hubbard C, McNamara JT, Azumaya C, Patel MS, Zimmer J. The hyaluronan synthase catalyzes the synthesis and membrane translocation of hyaluronan. J Mol Biol (2012) 418(1-2):21-31. doi:10.1016/j.jmb.2012.01.053
37. Medina AP, Lin J, Weigel PH. Hyaluronan synthase mediates dye translocation across liposomal membranes. BMC Biochem (2012) 13:2. doi:10.1186/1471-2091-13-2
38. Vigetti D, Genasetti A, Karousou E, Viola M, Clerici M, Bartolini B, et al. Modulation of hyaluronan synthase activity in cellular membrane fractions. J Biol Chem (2009) 284(44):30684-94. doi:10.1074/jbc.M109.040386
39. Kultti A, Pasonen-Seppänen S, Jauhiainen M, Rilla KJ, Kärnä R, Pyoriä E, et al. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res (2009) 315:1914-23. doi:10.1016/j.yexcr.2009.03.002
40. Jacobson A, Brinck J, Briskin MJ, Spicer AP, Heldin P. Expression of human hyaluronan synthases in response to external stimuli. Biochem J (2000) 348(Pt 1):29-35. doi:10.1042/0264-6021:3480029
41. Recklies AD, White C, Melching L, Roughley PJ. Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J (2001) 354(Pt 1):17-24. doi:10.1042/0264-6021:3540017
42. Pienimäki JP, Rilla K, Fülop C, Sironen RK, Karvinen S, Pasonen S, et al. Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J Biol Chem (2001) 276(23):20428-35. doi:10.1074/jbc.M007601200
43. Karvinen S, Pasonen-Seppänen S, Hyttinen JM, Pienimäki JP, Törrönen K, Jokela TA, et al. Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3. J Biol Chem (2003) 278(49):49495-504. doi:10.1074/jbc.M310445200
44. Yamada Y, Itano N, Hata K, Ueda M, Kimata K. Differential regulation by IL-1beta and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts: quantitative analysis using real-time RT-PCR. J Invest Dermatol (2004) 122(3):631-9. doi:10.1111/j.0022-202X.2004.22332.x
45. Stuhlmeier KM, Pollaschek C. Differential effect of transforming growth factor beta (TGF-beta) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-beta-induced hyaluronan synthase 1 activation. J Biol Chem (2004) 279(10):8753-60. doi:10.1074/jbc.M303945200
46. Oguchi T, Ishiguro N. Differential stimulation of three forms of hyaluronan synthase by TGF-beta, IL-1beta, and TNF-alpha. Connect Tissue Res (2004) 45(4-5):197-205. doi:10.1080/03008200490523031
47. Uchiyama T, Sakuta T, Kanayama T. Regulation of hyaluronan synthases in mouse uterine cervix. Biochem Biophys Res Commun (2005) 327(3):927-32. doi:10.1016/j.bbrc.2004.12.092
48. van Zeijl CJ, Fliers E, van Koppen CJ, Surovtseva OV, de Gooyer ME, Mourits MP, et al. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. Thyroid (2010) 20(5):535-44. doi:10.1089/thy.2009.0447
49. Kao JJ. The NF-kappaB inhibitor pyrrolidine dithiocarbamate blocks IL-1beta induced hyaluronan synthase 1 (HAS1) mRNA transcription, pointing at NF-kappaB dependence of the gene HAS1. Exp Gerontol (2006) 41(6):641-7. doi:10.1016/j.exger.2006.04.003
50. Stuhlmeier KM. Effects of leflunomide on hyaluronan synthases (HAS): NF-kappa B-independent suppression of IL-1-induced HAS1 transcription by leflunomide. J Immunol (2005) 174(11):7376-82. doi:10.4049/jimmunol.174.11.7376
51. Stuhlmeier KM, Pollaschek C. Glucocorticoids inhibit induced and non-induced mRNA accumulation of genes encoding hyaluronan synthases (HAS): hydrocortisone inhibits HAS1 activation by blocking the p38 mitogen-activated protein kinase signalling pathway. Rheumatology (Oxford) (2004) 43(2):164-9. doi:10.1093/rheumatology/keh014
52. Tsui S, Fernando R, Chen B, Smith TJ. Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease. J Biol Chem (2011) 286(27):24487-99. doi:10.1074/jbc.M111.241166
53. Chen L, Neville RD, Michael DR, Martin J, Luo DD, Thomas DW, et al. Identification and analysis of the human hyaluronan synthase 1 gene promoter reveals Smad3-and Sp3-mediated transcriptional induction. Matrix Biol (2012) 31(7-8):373-9. doi:10.1016/j.matbio.2012.10.002
54. Rauhala L, Hämäläinen L, Salonen P, Bart G, Tammi M, Pasonen-Seppänen S, et al. Low dose ultraviolet B irradiation increases hyaluronan synthesis in epidermal keratinocytes via sequential induction of hyaluronan synthases Has1-3 mediated by p38 and Ca2+/calmodulin-dependent protein kinase II (CaMKII) signaling. J Biol Chem (2013) 288(25):17999-8012. doi:10.1074/jbc.M113.472530
55. Decleves AE, Caron N, Voisin V, Legrand A, Bouby N, Kultti A, et al. Synthesis and fragmentation of hyaluronan in renal ischaemia. Nephrol Dial Transplant (2012) 27(10):3771-81. doi:10.1093/ndt/gfs098
56. Eldridge L, Moldobaeva A, Wagner EM. Increased hyaluronan fragmentation during pulmonary ischemia. Am J Physiol Lung Cell Mol Physiol (2011) 301(5):L782-8. doi:10.1152/ajplung.00079.2011
57. Zhuang Y, Yin Q. Peroxisome proliferator-activated receptor gamma agonists attenuate hyperglycaemia-induced hyaluronan secretion in vascular smooth muscle cells by inhibiting PKCbeta2. Cell Biochem Biophys (2013) 67(2):583-90. doi:10.1007/s12013-013-9545-4
58. Shimabukuro Y, Ueda M, Ichikawa T, Terashi Y, Yamada S, Kusumoto Y, et al. Fibroblast growth factor-2 stimulates hyaluronan production by human dental pulp cells. J Endod (2005) 31(11):805-8. doi:10.1097/01.don.0000158242.44155.49
59. Shimabukuro Y, Ichikawa T, Takayama S, Yamada S, Takedachi M, Terakura M, et al. Fibroblast growth factor-2 regulates the synthesis of hyaluronan by human periodontal ligament cells. J Cell Physiol (2005) 203(3):557-63. doi:10.1002/jcp.20256
60. Kuroda K, Utani A, Hamasaki Y, Shinkai H. Up-regulation of putative hyaluronan synthase mRNA by basic fibroblast growth factor and insulin-like growth factor-1 in human skin fibroblasts. J Dermatol Sci (2001) 26(2):156-60. doi:10.1016/S0923-1811(00)00155-9
61. Kaback LA, Smith TJ. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (1999) 84(11):4079-84. doi:10.1210/jcem.84.11.6111
62. Li L, Asteriou T, Bernert B, Heldin CH, Heldin P. Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem J (2007) 404(2):327-36. doi:10.1042/BJ20061757
63. Guo N, Baglole CJ, O'Loughlin CW, Feldon SE, Phipps RP. Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease. J Biol Chem (2010) 285(21):15794-804. doi:10.1074/jbc.M109.074534
64. Stuhlmeier KM. Prostaglandin E2: a potent activator of hyaluronan synthase 1 in type-B-synoviocytes. Biochim Biophys Acta (2007) 1770(1):121-9. doi:10.1016/j.bbagen.2006.07.001
65. Sugiyama Y, Shimada A, Sayo T, Sakai S, Inoue S. Putative hyaluronan synthase mRNA are expressed in mouse skin and TGF-beta upregulates their expression in cultured human skin cells. J Invest Dermatol (1998) 110(2):116-21. doi:10.1046/j.1523-1747.1998.00093.x
66. Freudenberger T, Rock K, Dai G, Dorn S, Mayer P, Heim HK, et al. Estradiol inhibits hyaluronic acid synthase 1 expression in human vascular smooth muscle cells. Basic Res Cardiol (2011) 106(6):1099-109. doi:10.1007/s00395-011-0217-5
67. Vigetti D, Rizzi M, Viola M, Karousou E, Genasetti A, Clerici M, et al. The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells. Glycobiology (2009) 19(5):537-46. doi:10.1093/glycob/cwp022
68. Kawakami M, Suzuki K, Matsuki Y, Ishizuka T, Hidaka T, Konishi T, et al. Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1 beta but inhibited by transforming growth factor beta 1. Ann Rheum Dis (1998) 57(10):602-5. doi:10.1136/ard.57.10.602
69. Goentzel BJ, Weigel PH, Steinberg RA. Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells. Biochem J (2006) 396(2):347-54. doi:10.1042/BJ20051782
70. Karousou E, Kamiryo M, Skandalis SS, Ruusala A, Asteriou T, Passi A, et al. The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J Biol Chem (2010) 285(31):23647-54. doi:10.1074/jbc.M110.127050
71. Vigetti D, Deleonibus S, Moretto P, Karousou E, Viola M, Bartolini B, et al. Role of UDP-N-acetylglucosamine (GlcNAc) and O-glcnacylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis. J Biol Chem (2012) 287(42):35544-55. doi:10.1074/jbc.M112.402347
72. Vigetti D, Clerici M, Deleonibus S, Karousou E, Viola M, Moretto P, et al. Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells. J Biol Chem (2011) 286(10):7917-24. doi:10.1074/jbc.M110.193656
73. Ghosh A, Kuppusamy H, Pilarski LM. Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer. J Biol Chem (2009) 284(28):18840-50. doi:10.1074/jbc.M109.013813
74. Pummill PE, DeAngelis PL. Alteration of polysaccharide size distribution of a vertebrate hyaluronan synthase by mutation. J Biol Chem (2003) 278(22):19808-14. doi:10.1074/jbc.M301097200
75. Pummill PE, Achyuthan AM, DeAngelis PL. Enzymological characterization of recombinant Xenopus DG42, a vertebrate hyaluronan synthase. J Biol Chem (1998) 273(9):4976-81. doi:10.1074/jbc.273.9.4976
76. Brinck J, Heldin P. Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp Cell Res (1999) 252(2):342-51. doi:10.1006/excr.1999.4645
77. Wilkinson TS, Bressler SL, Evanko SP, Braun KR, Wight TN. Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J Cell Physiol (2006) 206(2):378-85. doi:10.1002/jcp.20468
78. Müllegger J, Rustom A, Kreil G, Gerdes HH, Lepperdinger G. 'Piggy-back' transport of Xenopus hyaluronan synthase (XHAS1) via the secretory pathway to the plasma membrane. Biol Chem (2003) 384(1):175-82. doi:10.1515/BC.2003.019
79. Rilla K, Siiskonen H, Spicer AP, Hyttinen JM, Tammi MI, Tammi RH. Plasma membrane residence of hyaluronan synthase is coupled to its enzymatic activity. J Biol Chem (2005) 280(36):31890-7. doi:10.1074/jbc.M504736200
80. Spicer AP, Nguyen TK. Mammalian hyaluronan synthases: investigation of functional relationships in vivo. Biochem Soc Trans (1999) 27(2):109-15.
81. Rilla K, Tiihonen R, Kultti A, Tammi M, Tammi R. Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions. J Histochem Cytochem (2008) 56(10):901-10. doi:10.1369/jhc.2008.951665
82. Kanomata N, Yokose T, Kamijo T, Yonou H, Hasebe T, Itano N, et al. Hyaluronan synthase expression in pleural malignant mesotheliomas. Virchows Arch (2005) 446(3):246-50. doi:10.1007/s00428-004-1197-8
83. Nykopp TK, Rilla K, Sironen R, Tammi MI, Tammi RH, Hämäläinen K, et al. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content. BMC Cancer (2009) 9:143. doi:10.1186/1471-2407-9-143
84. Nykopp TK, Rilla K, Tammi MI, Tammi RH, Sironen R, Hämäläinen K, et al. Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. BMC Cancer (2010) 10:512. doi:10.1186/1471-2407-10-512
85. Siiskonen H, Poukka M, Tyynelä-Korhonen K, Sironen R, Pasonen-Seppänen S. Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer (2013) 13:181. doi:10.1186/1471-2407-13-181
86. Raheem KA, Marei WF, Mifsud K, Khalid M, Wathes DC, Fouladi-Nashta AA. Regulation of the hyaluronan system in ovine endometrium by ovarian steroids. Reproduction (2013) 145(5):491-504. doi:10.1530/REP-13-0001
87. Siponen M, Kullaa A, Nieminen P, Salo T, Pasonen-Seppänen S. Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus. J Oral Pathol Med (2014). doi:10.1111/jop.12294
88. Vigetti D, Deleonibus S, Moretto P, Bowen T, Fischer JW, Grandoch M, et al. Natural antisense transcript for hyaluronan synthase 2 (HAS2-AS1) induces transcription of HAS2 via protein O-GlcNAcylation. J Biol Chem (2014) 289(42):28816-26. doi:10.1074/jbc.M114.597401
89. Magee C, Nurminskaya M, Linsenmayer TF. UDP-glucose pyrophosphorylase: up-regulation in hypertrophic cartilage and role in hyaluronan synthesis. Biochem J (2001) 360(Pt 3):667-74. doi:10.1042/0264-6021:3600667
90. Vigetti D, Ori M, Viola M, Genasetti A, Karousou E, Rizzi M, et al. Molecular cloning and characterization of UDP-glucose dehydrogenase from the amphibian Xenopus laevis and its involvement in hyaluronan synthesis. J Biol Chem (2006) 281(12):8254-63. doi:10.1074/jbc.M508516200
91. Jokela TA, Jauhiainen M, Auriola S, Kauhanen M, Tiihonen R, Tammi MI, et al. Mannose inhibits hyaluronan synthesis by down-regulation of the cellular pool of UDP-N-acetylhexosamines. J Biol Chem (2008) 283(12):7666-73. doi:10.1074/jbc.M706001200
92. Petrey AC, de la Motte CA. Hyaluronan, a crucial regulator of inflammation. Front Immunol (2014) 5:101. doi:10.3389/fimmu.2014.00101
93. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol (2006) 85(8):699-715. doi:10.1016/j.ejcb.2006.05.009
94. Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem (2007) 282(25):18265-75. doi:10.1074/jbc.M606352200
95. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med (2002) 195(1):99-111. doi:10.1084/jem.20001858
96. Voelcker V, Gebhardt C, Averbeck M, Saalbach A, Wolf V, Weih F, et al. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol (2008) 17(2):100-7. doi:10.1111/j.1600-0625.2007.00638.x
97. Hyc A, Osiecka-Iwan A, Niderla-Bielinska J, Jankowska-Steifer E, Moskalewski S. Pro-and anti-inflammatory cytokines increase hyaluronan production by rat synovial membrane in vitro. Int J Mol Med (2009) 24(4):579-85. doi:10.3892/ijmm_00000268
98. Fischer JW, Schror K. Regulation of hyaluronan synthesis by vasodilatory prostaglandins. Implications for atherosclerosis. Thromb Haemost (2007) 98(2):287-95. doi:10.1160/TH07-02-0155
99. van den Boom M, Sarbia M, von Wnuck Lipinski K, Mann P, Meyer-Kirchrath J, Rauch BH, et al. Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res (2006) 98(1):36-44. doi:10.1161/01.RES.0000199263.67107.c0
100. Marzoll A, Nagy N, Wordehoff L, Dai G, Fries S, Lindner V, et al. Cyclooxygenase inhibitors repress vascular hyaluronan-synthesis in murine atherosclerosis and neointimal thickening. J Cell Mol Med (2009) 13(9B):3713-9. doi:10.1111/j.1582-4934.2009.00736.x
101. David-Raoudi M, Deschrevel B, Leclercq S, Galera P, Boumediene K, Pujol JP. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: role of p38 and Akt. Arthritis Rheum (2009) 60(3):760-70. doi:10.1002/art.24302
102. Chang MY, Tanino Y, Vidova V, Kinsella MG, Chan CK, Johnson PY, et al. Reprint of: a rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biol (2014) 35:162-73. doi:10.1016/j.matbio.2014.04.003
103. Gelse K, Ekici AB, Cipa F, Swoboda B, Carl HD, Olk A, et al. Molecular differentiation between osteophytic and articular cartilage-clues for a transient and permanent chondrocyte phenotype. Osteoarthritis Cartilage (2012) 20(2):162-71. doi:10.1016/j.joca.2011.12.004
104. Yoshida M, Sai S, Marumo K, Tanaka T, Itano N, Kimata K, et al. Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction. Arthritis Res Ther (2004) 6(6):R514-20. doi:10.1186/ar1223
105. Kultti A, Rilla K, Tiihonen R, Spicer AP, Tammi RH, Tammi MI. Hyaluronan synthesis induces microvillus-like cell surface protrusions. J Biol Chem (2006) 281(23):15821-8. doi:10.1074/jbc.M512840200
106. Jokela TA, Lindgren A, Rilla K, Maytin E, Hascall VC, Tammi RH, et al. Induction of hyaluronan cables and monocyte adherence in epidermal keratinocytes. Connect Tissue Res (2008) 49(3):115-9. doi:10.1080/03008200802148439
107. Meran S, Martin J, Luo DD, Steadman R, Phillips A. Interleukin-1beta induces hyaluronan and CD44-dependent cell protrusions that facilitate fibroblast-monocyte binding. Am J Pathol (2013) 182(6):2223-40. doi:10.1016/j.ajpath.2013.02.038
108. Engström-Laurent A, Hallgren R. Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum (1987) 30(12):1333-8. doi:10.1002/art.1780301203
109. Tanimoto K, Ohno S, Fujimoto K, Honda K, Ijuin C, Tanaka N, et al. Proinflammatory cytokines regulate the gene expression of hyaluronic acid synthetase in cultured rabbit synovial membrane cells. Connect Tissue Res (2001) 42(3):187-95. doi:10.3109/03008200109005649
110. Stuhlmeier KM. Hyaluronan production in synoviocytes as a consequence of viral infections: HAS1 activation by Epstein-Barr virus and synthetic double-and single-stranded viral RNA analogs. J Biol Chem (2008) 283(24):16781-9. doi:10.1074/jbc.M801669200
111. Cheng G, Swaidani S, Sharma M, Lauer ME, Hascall VC, Aronica MA. Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma. Matrix Biol (2011) 30(2):126-34. doi:10.1016/j.matbio.2010.12.003
112. Cheng G, Swaidani S, Sharma M, Lauer ME, Hascall VC, Aronica MA. Correlation of hyaluronan deposition with infiltration of eosinophils and lymphocytes in a cockroach-induced murine model of asthma. Glycobiology (2013) 23(1):43-58. doi:10.1093/glycob/cws122
113. Zhang L, Bowen T, Grennan-Jones F, Paddon C, Giles P, Webber J, et al. Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem (2009) 284(39):26447-55. doi:10.1074/jbc.M109.003616
114. Yabushita H, Noguchi M, Kishida T, Fusano K, Noguchi Y, Itano N, et al. Hyaluronan synthase expression in ovarian cancer. Oncol Rep (2004) 12(4):739-43. doi:10.3892/or.12.4.739
115. Weiss I, Trope CG, Reich R, Davidson B. Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure. Int J Mol Sci (2012) 13(10):12925-38. doi:10.3390/ijms131012925
116. Yamada Y, Itano N, Narimatsu H, Kudo T, Morozumi K, Hirohashi S, et al. Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin Exp Metastasis (2004) 21(1):57-63. doi:10.1023/B:CLIN.0000017203.71293.e0
117. Kramer MW, Escudero DO, Lokeshwar SD, Golshani R, Ekwenna OO, Acosta K, et al. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis. Cancer (2011) 117(6):1197-209. doi:10.1002/cncr.25565
118. Golshani R, Lopez L, Estrella V, Kramer M, Iida N, Lokeshwar VB. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res (2008) 68(2):483-91. doi:10.1158/0008-5472.CAN-07-2140
119. Auvinen P, Tammi R, Parkkinen J, Tammi M, Ågren U, Johansson R, et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol (2000) 156(2):529-36. doi:10.1016/S0002-9440(10)64757-8
120. Auvinen P, Tammi R, Kosma VM, Sironen R, Soini Y, Mannermaa A, et al. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer. Int J Cancer (2013) 132(3):531-9. doi:10.1002/ijc.27707
121. Karjalainen JM, Tammi RH, Tammi MI, Eskelinen MJ, Ågren UM, Parkkinen JJ, et al. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am J Pathol (2000) 157(3):957-65. doi:10.1016/S0002-9440(10)64608-1